Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Kona SUV: The Courageous Minimized That is Catching Hearts Around the world - 2Flu cases are rising with a strain that makes older people sicker
- 3The Most Famous Virtual Entertainment Powerhouses of the Year
- 4The most effective method to Decisively Plan Your Nursing Profession for the Best Compensation Results
- 5Faulty glucose monitors linked to 7 deaths and more than 700 injuries, FDA warns
- Dave Coulier shares new cancer diagnosis 1 year after revealing previous diagnosis
- With more Moon missions on the horizon, avoiding crowding and collisions will be a growing challenge
- The Best 10 Innovation Advancements of the Year
- The most effective method to Connect Successfully with Teachers in a Web based Setting
- Starbucks' new 'Bearista' cup is causing a stir — and is being listed on eBay for $600
- The Way to Business: Startup Illustrations Learned
- Zelensky confidant dismissed from further posts amid bribery scandal
- ‘The White Lotus’ sparked online interest in risky anxiety pills, study says
- Merck sees over $5 billion opportunity in Cidara's experimental flu drug
